CRLF2 and acute lymphoblastic leukemia: Rearrangements of CRLF2 account for 24% of pediatric patients with NCI SR Ph-like ALL [9], 55% of children with HR disease [10] and 50% to 60% of adolescent and adult patients with Ph-like ALL cases [4,11,12,13,17,18].